Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. · 66-66 · JAPAN

For Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd., import alert is 66-66; country is JAPAN; import alert name is "APIs That Appear To Be Misbranded Under 502(f)(1) Because They Do Not Meet The Requirements For The Labeling Exemptions In 21 CFR 201.122"; product is Agent for Schizophrenia | OPC-14597 - Agent | Mucosta; product code is 65 A - S 99 Memory Adjuvant, N.E.C., Active Pharm Ingred/Chems for Further Manuf | 65 A - S 99 Memory Adjuvant, N.E.C., Active Pharm Ingred/Chems for Further Manuf | 66 V - - 99 Miscellaneous Patent Medicines, Etc; date published is 09/30/2009; address is 224-18 , Kawauchi-Cho , Tokushima, Tokushima JAPAN, verified against its source on 2026-09-30.

What the source says

Second Tokushima Factory, Otsuka Pharmaceutical Co., Ltd. Date Published : 09/30/2009 224-18 , Kawauchi-Cho , Tokushima, Tokushima JAPAN

— accessdata.fda.gov, retrieved 2026-09-15

Where each value comes from

The values above are stated away from the sentence quoted with the answer, so the passage that states them is shown here too.

— all from accessdata.fda.gov, retrieved 2026-09-15

Source

• accessdata.fda.govhttps://www.accessdata.fda.gov/cms_ia/importalert_202.html

Last verified against source: 2026-09-30. Due for re-check by 2026-11-29. This page as Markdown · OKF bundle · full dataset as JSON.